Skip to main content
H.R. 19 116th Congress House

Lower Costs, More Cures Act of 2019

Official title: To provide for certain reforms with respect to the Medicare program under title XVIII of the Social Security Act, the Medicaid program under title XIX of such … Show full official titleShow less

Official title: To provide for certain reforms with respect to the Medicare program under title XVIII of the Social Security Act, the Medicaid program under title XIX of such Act, the Food and Drug Administration, and for other purposes.

Introduced: December 9, 2019 See on congress.gov
Health Administrative law and regulatory proceduresAdministrative remediesAdvisory bodiesAppropriations
More subjectsShow fewer subjects
Biological and life sciencesBusiness recordsCancerChemistryChild healthCivil actions and liabilityCompetition and antitrustCongressional oversightConsumer affairsCorporate finance and managementCosmetics and personal careDepartment of Health and Human ServicesDigestive and metabolic diseasesDrug safety, medical device, and laboratory regulationDrug therapyExecutive agency funding and structureFederal Trade Commission (FTC)Food and Drug Administration (FDA)Fraud offenses and financial crimesGeneticsGovernment information and archivesGovernment studies and investigationsHealth care costs and insuranceHealth information and medical recordsHealth personnelHealth programs administration and fundingHealth technology, devices, suppliesHome and outpatient careHospital careImmunology and vaccinationIncome tax deductionsIncome tax exclusionInflation and pricesIntellectual propertyIntergovernmental relationsJudicial review and appealsLicensing and registrationsManufacturingMarketing and advertisingMedicaidMedical educationMedical researchMedical tests and diagnostic methodsMedicareOffice of the U.S. Trade RepresentativePrescription drugsProduct development and innovationPublic participation and lobbyingResearch and developmentRetail and wholesale tradesState and local government operationsTrade agreements and negotiationsUser charges and feesWomen's health
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 19, 2019
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Dec 10, 2019
Referred to the Subcommittee on Health.
Dec 9, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Dec 9, 2019
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action December 19, 2019

Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.

 Plain-English summary Congressional Research Service

Lower Costs, More Cures Act of 2019

This bill establishes and modifies several requirements to address prescription drug prices under Medicare, Medicaid, and other programs.

The bill generally

  • limits payment amounts for drugs and biologics under Medicare medical services,
  • reduces cost-sharing under the Medicare prescription drug benefit,
  • modifies certain authorities and requirements under the Medicaid Drug Rebate Program,
  • revises provisions relating to regulatory approval and commercial availability of generics and biosimilars, and
  • establishes several reporting requirements for drug manufacturers with respect to drug prices.
 Related & companion bills 34
  • HR 4400 Advancing Education on Biosimilars Act of 2019
  • HR 2700 Lowering Prescription Drug Costs and Extending Community Health Centers and Other Public Health Priorities Act
  • HR 938 BLOCKING Act of 2019
  • HR 965 CREATES Act of 2019
  • HR 1499 Protecting Consumer Access to Generic Drugs Act of 2019
  • HR 1503 Orange Book Transparency Act of 2020
  • HR 1520 Further Extension of Continuing Appropriations Act, 2021
  • HR 2296 More Efficient Tools to Realize Information for Consumers Act
  • HR 2376 Prescription Pricing for the People Act of 2019
  • HR 3443 To clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved…
Show all 34 related billsShow fewer related bills
  • HR 5281 Drug Price Transparency in Medicaid Act of 2019
  • S 1227 Prescription Pricing for the People Act of 2019
  • S 1636 Ensuring Innovation Act
  • S 2740 Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019
  • HR 1264 Payment Commission Data Act of 2019
  • HR 1781 Payment Commission Data Act of 2019
  • HR 1922 Restoring Access to Medication Act of 2019
  • HR 2087 Drug Price Transparency Act
  • HR 2115 Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act
  • HR 3029 Improving Low-Income Access to Prescription Drugs Act of 2019
  • HR 3408 Shop Rx Act of 2019
  • HR 3415 Real-Time Beneficiary Drug Cost Bill
  • HR 5444 Lower Insulin Costs Now Act
  • S 801 A bill to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and…
  • S 1999 Improving Low Income Access to Prescription Drugs Act of 2019
  • S 2051 Strengthening Average Sales Price Reporting Act of 2019
  • S 3013 Encouraging Innovative Benefit Design to Lower Costs for Seniors Act
  • HR 5882 GENE Therapy Payment Act
  • S 3942 Securing America’s Medical Supply Chain and Advancing the Production of Life Saving Medicines Act
  • HR 6155 To amend the Biologics Price Competition and Innovation Act of 2009 to make improvements with respect to the transition…
  • HR 7877 Lowering Drug Costs for Seniors Act of 2020
  • HR 7898 To amend the Health Information Technology for Economic and Clinical Health Act to require the Secretary of Health and …
  • S 3129 Lower Costs, More Cures Act of 2019
  • HR 4955 Protecting Access to Safe and Effective Medicines Act of 2019
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 5
 Cosponsors 147
All 147 Republican 87
Brooks, Mo
· Aug 18, 2020
 R
Wittman, Robert J.
Virginia · Jan 29, 2020
 R
Crawford, Eric A. "Rick"
Arkansas · Jan 8, 2020
Bishop, Dan
· Dec 18, 2019
 R
DesJarlais, Scott
Tennessee · Dec 18, 2019
 R
Gooden, Lance
Texas · Dec 18, 2019
 R
Timmons, William R.
South Carolina · Dec 18, 2019
Armstrong, Kelly
· Dec 13, 2019
 R
Bergman, Jack
Michigan · Dec 13, 2019
 R
Fulcher, Russ
Idaho · Dec 13, 2019
Hice, Jody
· Dec 13, 2019
 R
Simpson, Michael K.
Idaho · Dec 13, 2019
 R
Burchett, Tim
Tennessee · Dec 11, 2019
 R
Carter, John R.
Texas · Dec 11, 2019
Mooney, Alexander
· Dec 11, 2019
 R
Perry, Scott
Pennsylvania · Dec 11, 2019
 R
Scott, Austin
Georgia · Dec 11, 2019
THORNBERRY, WILLIAM
· Dec 11, 2019
Zeldin, Lee
· Dec 11, 2019
 R
Bacon, Don
Nebraska · Dec 10, 2019
 R
Barr, Andy
Kentucky · Dec 10, 2019
 R
Bost, Mike
Illinois · Dec 10, 2019
Byrne, Bradley
· Dec 10, 2019
Duncan, Jeff
· Dec 10, 2019
 R
Dunn, Neal P.
Florida · Dec 10, 2019
Granger, Kay
· Dec 10, 2019
 R
Harris, Andy
Maryland · Dec 10, 2019
Katko, John
· Dec 10, 2019
KING, PETER
· Dec 10, 2019
 R
Meuser, Daniel
Pennsylvania · Dec 10, 2019
 R
Moolenaar, John R.
Michigan · Dec 10, 2019
 R
Rogers, Harold
Kentucky · Dec 10, 2019
 R
Smucker, Lloyd
Pennsylvania · Dec 10, 2019
Spano, Ross
· Dec 10, 2019
 R
Webster, Daniel
Florida · Dec 10, 2019
 R
Womack, Steve
Arkansas · Dec 10, 2019
Abraham, Ralph
· Dec 9, 2019
 R
Aderholt, Robert B.
Alabama · Dec 9, 2019
 R
Allen, Rick W.
Georgia · Dec 9, 2019
 R
Amodei, Mark E.
Nevada · Dec 9, 2019
 R
Arrington, Jodey C.
Texas · Dec 9, 2019
 R
Babin, Brian
Texas · Dec 9, 2019
 R
Baird, James R.
Indiana · Dec 9, 2019
 R
Balderson, Troy
Ohio · Dec 9, 2019
 R
Banks, Jim
Indiana · Dec 9, 2019
 R
Bilirakis, Gus M.
Florida · Dec 9, 2019
BRADY, KEVIN
· Dec 9, 2019
Brooks, Susan
· Dec 9, 2019
 R
Buchanan, Vern
Florida · Dec 9, 2019
Bucshon, Larry
· Dec 9, 2019
Page 1 of 3 Next
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 19: Lower Costs, More Cures Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-HR-19/
MLA
"H.R. 19: Lower Costs, More Cures Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-19/.
Bluebook (legal)
H.R. 19, 116th Cong. (2026), https://openamerica.io/bill/116-HR-19/.
Markdown link
[H.R. 19: Lower Costs, More Cures Act of 2019](https://openamerica.io/bill/116-HR-19/)
Report a problem